AppNexus operates a cloud-based software platform that enables and optimizes programmatic online advertising.
AppNexus operates a cloud-based software platform that enables and optimizes programmatic online advertising. Its enterprise technology platform maximizes yield and campaign performance for sellers and buyers of online inventory, provides trading solutions and marketplaces for Internet advertising, and allows advertisers to build a trading desk, an advertising network, and a custom exchange. AppNexus also provides a digital advertising delivery platform that enables publisher clients to maximize revenue across various demand sources, AppNexus Publisher Suite that powers advertisement serving, planning and forecasting, diverse marketplace sales, and direct campaign management solutions, PriceCheck, a header bidding solution for banner, video, and interstitial advertising units, and AppNexus Apps program, an application platform for third-party technology vendors and existing customers to build features for their own clients and reach new audiences. Brian O'Kelley and Mike Nolet founded AppNexus in September 2007, with its headquarters in New York City and additional offices in several cities in the United States and other countries.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 28, 2016 | Series Unknown | $31M | 1 | News Corp | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 18, 2022
Isabl Inc.
|
Seed | $3M | Biotechnology | — |
Apr 28, 2022
CytoTronics
|
Seed | $9.25M | Test and Measurement | — |
Mar 9, 2022
Colossal Biosciences
|
Series A | $60M | Biotechnology | — |
May 12, 2021
Juno Diagnostics
|
Series A | $25M | Biotechnology | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
News Corp | Yes | Series Unknown |